To determine if post-LPS inhibition of TRPV4 channels afforded protection against sepsis, we examined survival rates in the LPS model in mice administered a TRPV4 antagonist 2 or 4 hours after LPS. The gene discussed is TRPV4; the disease is Sepsis.